NAFLD Increases Risk for Severe Infections

NAFLD Increases Risk for Severe Infections

People with nonalcoholic fatty liver disease (NAFLD) are more likely to develop severe infections requiring hospitalization, according to findings from a large Swedish cohort study. The increased risk was equal to one extra severe infection in every six patients with…

Read More
CGRP Offers Relief From Migraine and Comorbid Depression

CGRP Offers Relief From Migraine and Comorbid Depression

Treatment with the anticalcitonin gene-related peptide (CGRP) fremanezumab (Ajovy, Teva Pharmaceuticals Inc) reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD), new research shows. Patients with both conditions who were randomly assigned to receive fremanezumab showed…

Read More